This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ASM journals
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Furman, P A
Right arrow Articles by Fyfe, J A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Furman, P A
Right arrow Articles by Fyfe, J A

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1992 December; 36(12): 2686-2692

The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine.

P A Furman, M Davis, D C Liotta, M Paff, L W Frick, D J Nelson, R E Dornsife, J A Wurster, L J Wilson and J A Fyfe

Division of Virology, Burroughs Wellcome Co., Research Triangle Park, North Carolina 27709.

ABSTRACT

The anti-hepatitis B (anti-HBV) activities of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine (2'-deoxy-3'-thia-5-fluorocytosine [FTC]) were studied by using an HBV-transfected cell line (HepG2 derivative 2.2.15, subclone P5A). The (-) isomer was found to be a potent inhibitor of viral replication, with an apparent 50% inhibitory concentration of 10 nM, while the (+) isomer was found to be considerably less active. Both isomers showed minimal toxicity to HepG2 cells (50% inhibitory concentration, > 200 microM) and showed minimal toxicity in the human bone marrow progenitor cell assay. In accord with the cellular antiviral activity data, the 5'-triphosphate of (-)-FTC inhibited viral DNA synthesis in an endogenous HBV DNA polymerase assay, while the 5'-triphosphate of the (+) isomer was inactive. Unphosphorylated (-)-FTC did not inhibit product formation in the endogenous assay, suggesting that the antiviral activity of the compound is dependent on anabolism to the 5'-triphosphate. Both (-)- and (+)-FTC were anabolized to the corresponding 5'-triphosphates in chronically HBV-infected HepG2 cells. The rate of accumulation and the steady-state concentration of the 5'-triphosphate of (-)-FTC were greater. Also, (-)-FTC was not a substrate for cytidine deaminase and, therefore, is not subject to deamination and conversion to an inactive uridine analog. The (+) isomer is, however, a good substrate for cytidine deaminase.

Antimicrob Agents Chemother. 1992 December; 36(12): 2686-2692




This article has been cited by other articles:

  • Lim, S. G., Ng, T. M., Kung, N., Krastev, Z., Volfova, M., Husa, P., Lee, S. S., Chan, S., Shiffman, M. L., Washington, M. K., Rigney, A., Anderson, J., Mondou, E., Snow, A., Sorbel, J., Guan, R., Rousseau, F., for the Emtricitabine FTCB-301 Study Group, (2006). A Double-blind Placebo-Controlled Study of Emtricitabine in Chronic Hepatitis B. Arch Intern Med 166: 49-56 [Abstract] [Full Text]  
  • Herzmann, C., Arasteh, K., Murphy, R. L., Schulbin, H., Kreckel, P., Drauz, D., Schinazi, R. F., Beard, A., Cartee, L., Otto, M. J. (2005). Safety, Pharmacokinetics, and Efficacy of (+/-)-{beta}-2',3'-Dideoxy-5-Fluoro-3'-Thiacytidine with Efavirenz and Stavudine in Antiretroviral-Naive Human Immunodeficiency Virus-Infected Patients. Antimicrob. Agents Chemother. 49: 2828-2833 [Abstract] [Full Text]  
  • Delaney, W. E. IV, Yang, H., Miller, M. D., Gibbs, C. S., Xiong, S. (2004). Combinations of Adefovir with Nucleoside Analogs Produce Additive Antiviral Effects against Hepatitis B Virus In Vitro. Antimicrob. Agents Chemother. 48: 3702-3710 [Abstract] [Full Text]  
  • Feng, J. Y., Murakami, E., Zorca, S. M., Johnson, A. A., Johnson, K. A., Schinazi, R. F., Furman, P. A., Anderson, K. S. (2004). Relationship between Antiviral Activity and Host Toxicity: Comparison of the Incorporation Efficiencies of 2',3'-Dideoxy-5-Fluoro-3'-Thiacytidine-Triphosphate Analogs by Human Immunodeficiency Virus Type 1 Reverse Transcriptase and Human Mitochondrial DNA Polymerase. Antimicrob. Agents Chemother. 48: 1300-1306 [Abstract] [Full Text]  
  • Karayiannis, P. (2003). Hepatitis B virus: old, new and future approaches to antiviral treatment. J Antimicrob Chemother 51: 761-785 [Abstract] [Full Text]  
  • Abdelhamed, A. M., Kelley, C. M., Miller, T. G., Furman, P. A., Cable, E. E., Isom, H. C. (2003). Comparison of Anti-Hepatitis B Virus Activities of Lamivudine and Clevudine by a Quantitative Assay. Antimicrob. Agents Chemother. 47: 324-336 [Abstract] [Full Text]  
  • Hernandez-Santiago, B., Placidi, L., Cretton-Scott, E., Faraj, A., Bridges, E. G., Bryant, M. L., Rodriguez-Orengo, J., Imbach, J. L., Gosselin, G., Pierra, C., Dukhan, D., Sommadossi, J. P. (2002). Pharmacology of {beta}-L-Thymidine and {beta}-L-2'-Deoxycytidine in HepG2 Cells and Primary Human Hepatocytes: Relevance to Chemotherapeutic Efficacy against Hepatitis B Virus. Antimicrob. Agents Chemother. 46: 1728-1733 [Abstract] [Full Text]  
  • Bryant, M. L., Bridges, E. G., Placidi, L., Faraj, A., Loi, A.-G., Pierra, C., Dukhan, D., Gosselin, G., Imbach, J.-L., Hernandez, B., Juodawlkis, A., Tennant, B., Korba, B., Cote, P., Marion, P., Cretton-Scott, E., Schinazi, R. F., Sommadossi, J.-P. (2001). Antiviral L-Nucleosides Specific for Hepatitis B Virus Infection. Antimicrob. Agents Chemother. 45: 229-235 [Abstract] [Full Text]  
  • Halvas, E. K., Svarovskaia, E. S., Freed, E. O., Pathak, V. K. (2000). Wild-Type and YMDD Mutant Murine Leukemia Virus Reverse Transcriptases Are Resistant to 2',3'-Dideoxy-3'-Thiacytidine. J. Virol. 74: 6669-6674 [Abstract] [Full Text]  
  • Korba, B. E., Schinazi, R. F., Cote, P., Tennant, B. C., Gerin, J. L. (2000). Effect of Oral Administration of Emtricitabine on Woodchuck Hepatitis Virus Replication in Chronically Infected Woodchucks. Antimicrob. Agents Chemother. 44: 1757-1760 [Abstract] [Full Text]  
  • Pelicano, H., Kukhanova, M., Cheng, Y.-C. (2000). Excision of beta -D- and beta -L-Nucleotide Analogs from DNA by the Human Cytosolic 3'-to-5' Exonuclease. Mol. Pharmacol. 57: 1051-1055 [Abstract] [Full Text]  
  • Placidi, L., Cretton-Scott, E., Gosselin, G., Pierra, C., Schinazi, R. F., Imbach, J.-L., el Kouni, M. H., Sommadossi, J.-P. (2000). Intracellular Metabolism of beta -L-2',3'-Dideoxyadenosine: Relevance to Its Limited Antiviral Activity. Antimicrob. Agents Chemother. 44: 853-858 [Abstract] [Full Text]  
  • Sosunov, V. V., Santamaria, F., Victorova, L. S., Gosselin, G., Rayner, B., Krayevsky, A. A. (2000). Stereochemical control of DNA biosynthesis. Nucleic Acids Res 28: 1170-1175 [Abstract] [Full Text]  
  • Darque, A., Valette, G., Rousseau, F., Wang, L. H., Sommadossi, J.-P., Zhou, X.-J. (1999). Quantitation of Intracellular Triphosphate of Emtricitabine in Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus-Infected Patients. Antimicrob. Agents Chemother. 43: 2245-2250 [Abstract] [Full Text]  
  • FENG, J. Y., SHI, J., SCHINAZI, R. F., ANDERSON, K. S. (1999). Mechanistic studies show that (-)-FTC-TP is a better inhibitor of HIV-1 reverse transcriptase than 3TC-TP. FASEB J. 13: 1511-1517 [Abstract] [Full Text]  
  • Sarafianos, S. G., Das, K., Clark, A. D. Jr., Ding, J., Boyer, P. L., Hughes, S. H., Arnold, E. (1999). Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with beta -branched amino acids. Proc. Natl. Acad. Sci. USA 96: 10027-10032 [Abstract] [Full Text]  
  • Dutschman, G. E., Bridges, E. G., Liu, S.-H., Gullen, E., Guo, X., Kukhanova, M., Cheng, Y.-C. (1998). Metabolism of 2',3'-Dideoxy-2',3'-Didehydro-beta -L(-)-5-Fluorocytidine and Its Activity in Combination with Clinically Approved Anti-Human Immunodeficiency Virus beta -D(+) Nucleoside Analogs In Vitro. Antimicrob. Agents Chemother. 42: 1799-1804 [Abstract] [Full Text]  
  • Zhu, Y.-L., Dutschman, G. E., Liu, S.-H., Bridges, E. G., Cheng, Y.-C. (1998). Anti-Hepatitis B Virus Activity and Metabolism of 2',3'-Dideoxy-2',3'-Didehydro-beta -L(-)-5-Fluorocytidine. Antimicrob. Agents Chemother. 42: 1805-1810 [Abstract] [Full Text]  
  • Liu, S.-H., Grove, K. L., Cheng, Y.-C. (1998). Unique Metabolism of a Novel Antiviral L-Nucleoside Analog, 2'-Fluoro-5-Methyl-beta -L-Arabinofuranosyluracil: a Substrate for Both Thymidine Kinase and Deoxycytidine Kinase. Antimicrob. Agents Chemother. 42: 833-839 [Abstract] [Full Text]  


Copyright © 2010 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»